IA-2 Antibody (IA-2A) Biomarker Testing
It measures an autoimmune antibody linked to type 1 diabetes risk and diagnosis, with easy ordering and Quest lab access through Vitals Vault.
With Vitals Vault, you have access to a comprehensive range of biomarker tests.
IA-2 Antibody (often shown as IA-2A) is one of the “islet autoantibodies” that can appear when your immune system targets the insulin-producing cells in your pancreas.
This test is not about how high your blood sugar is today. It is about whether an autoimmune process is likely contributing to diabetes now, or increasing the risk of developing type 1 diabetes in the future.
Because antibody results can be confusing and are best read alongside other labs, this test works best as part of clinician-directed care rather than a stand-alone self-diagnosis tool.
Do I need a IA 2 Antibody test?
You may want an IA-2 Antibody test if you have new or worsening high blood sugar and it is not clear whether you have type 1 diabetes, type 2 diabetes, or a slower-onset autoimmune form sometimes called LADA (latent autoimmune diabetes in adults). This question comes up often if you are lean or have unexpected weight loss, excessive thirst or urination, blurry vision, or fatigue, but symptoms alone cannot tell you which type you have.
This test can also be useful if you have a strong family history of type 1 diabetes or other autoimmune conditions and you are trying to understand risk. In some settings, clinicians use islet autoantibodies to help stratify risk and decide how closely to monitor glucose over time.
You generally do not need IA-2 antibody testing to manage typical type 2 diabetes that is stable and clearly insulin-resistant, especially if your clinician is confident in the diagnosis. However, if your blood sugar control is unexpectedly difficult, you need insulin earlier than expected, or you have episodes of ketosis, antibody testing can add clarity.
If you are pregnant or planning pregnancy and diabetes type is uncertain, your clinician may also consider antibody testing because the diagnosis can change monitoring and treatment decisions.
IA-2 antibody testing is performed on a blood sample in a CLIA-certified laboratory; results support diagnosis and risk assessment but do not diagnose diabetes on their own.
Lab testing
Order IA-2 antibody testing and add companion markers if you want a fuller autoimmune diabetes picture.
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this test with Vitals Vault
Vitals Vault lets you order IA-2 Antibody testing directly, so you can move from “I’m not sure what’s going on” to a clearer conversation with your clinician. After you order, you visit a participating lab location for a standard blood draw.
Your result is most useful when it is interpreted with related markers like GAD65 antibodies, ZnT8 antibodies, insulin autoantibodies (IAA), glucose or A1c, and C-peptide. If you already have results, PocketMD can help you understand what patterns typically mean and what follow-up questions to bring to your next appointment.
If you are tracking changes over time—such as after a new diagnosis, medication changes, or a major shift in glucose control—Vitals Vault makes it easy to reorder and trend your labs so you can see whether the overall picture is stable or evolving.
- Order online and complete your blood draw at a participating lab location
- PocketMD helps you interpret results in context and plan next steps
- Easy retesting when you and your clinician want to confirm or trend
Key benefits of IA 2 Antibody testing
- Helps distinguish autoimmune diabetes from type 2 diabetes when the diagnosis is unclear.
- Adds specificity when combined with other islet autoantibodies (GAD65, ZnT8, IAA).
- Supports earlier, safer treatment decisions if insulin deficiency is developing.
- Improves risk assessment in people with a family history of type 1 diabetes or other autoimmune disease.
- Helps explain unexpected clinical patterns, such as rapid progression to insulin or ketosis.
- Guides what follow-up labs matter most next (C-peptide, A1c, fasting glucose, ketones).
- Makes it easier to trend and revisit the diagnosis over time using consistent lab testing.
What is IA 2 Antibody?
IA-2 Antibody is an immune protein (autoantibody) that targets a pancreatic islet cell protein called insulinoma-associated antigen-2 (IA-2). When your immune system makes antibodies to IA-2, it suggests an autoimmune response against the insulin-producing beta cells.
IA-2 antibodies are one piece of the type 1 diabetes antibody “profile.” Some people have only one antibody, while others have multiple. In general, the more islet autoantibodies that are present, the more likely it is that autoimmune beta-cell damage is occurring or will occur.
A positive IA-2 antibody result does not tell you how much insulin your pancreas is making today. For that, clinicians often look at C-peptide (a marker of your own insulin production) along with glucose or A1c. The antibody result is more about cause and risk than day-to-day glucose levels.
How IA-2 fits into diabetes typing
When adults develop diabetes, it is sometimes labeled as type 2 by default. If IA-2 antibodies (and/or other islet antibodies) are positive, it raises the likelihood of autoimmune diabetes, which often progresses toward insulin dependence faster than typical type 2 diabetes.
IA-2 vs other islet autoantibodies
GAD65 antibodies are common in adult-onset autoimmune diabetes, while IA-2 antibodies can be more strongly associated with classic type 1 diabetes patterns in some populations. ZnT8 and insulin autoantibodies can add additional sensitivity. No single antibody is definitive in every person, so panels are often used.
What do my IA 2 Antibody results mean?
Low or negative IA-2 antibody
A low or negative result means IA-2 antibodies were not detected or were below the lab’s cutoff. This makes IA-2–related autoimmunity less likely, but it does not fully rule out autoimmune diabetes because other antibodies (like GAD65 or ZnT8) may still be positive. If diabetes type is still uncertain, your clinician may pair antibody testing with C-peptide and glucose/A1c to assess insulin production and overall control.
In-range (within the lab’s reference range)
For antibody tests, “in-range” typically means negative. In that situation, the test does not provide evidence of an IA-2 autoimmune response at the time of testing. If your symptoms, age at onset, body composition, or clinical course still suggest autoimmune diabetes, it is reasonable to discuss a broader islet autoantibody panel and a C-peptide level rather than relying on IA-2 alone.
High or positive IA-2 antibody
A high or positive result means IA-2 antibodies were detected above the lab’s cutoff, which supports an autoimmune process affecting pancreatic beta cells. This result is commonly used to support a diagnosis of type 1 diabetes or LADA when paired with glucose/A1c findings and clinical history. If multiple islet autoantibodies are positive, the likelihood of autoimmune diabetes is higher, and your clinician may monitor more closely for declining insulin production and the need for insulin therapy.
Factors that influence IA-2 antibody results
Different labs and methods can use different cutoffs, so “positive” is best interpreted using the reference range on your report and, when possible, by trending results at the same lab. Timing matters: antibodies may be more likely to be detected around diagnosis and can change over time. Having other autoimmune diseases can increase the chance of islet autoantibodies, but a positive result still needs to be interpreted with your glucose status. Treatments that strongly suppress the immune system can sometimes affect antibody detection, so tell your clinician about any immunosuppressive medications.
What’s included
- Ia-2 Antibody
Frequently Asked Questions
What does a positive IA-2 antibody mean?
A positive IA-2 antibody result means your immune system is making antibodies against an islet cell protein (IA-2), which supports an autoimmune process affecting pancreatic beta cells. It is commonly used to support type 1 diabetes or LADA when interpreted with glucose/A1c, symptoms, and often other antibodies and C-peptide.
Can IA-2 antibodies be positive in type 2 diabetes?
Most people with typical type 2 diabetes are negative for islet autoantibodies, but some people initially labeled as type 2 actually have autoimmune diabetes (often LADA). In that situation, IA-2 (or other islet antibodies) may be positive and can help clarify the diagnosis.
Should I test IA-2 antibody alone or as a panel?
If the goal is to clarify diabetes type or autoimmune risk, a panel is often more informative because some people are positive for GAD65 or ZnT8 but negative for IA-2. Testing multiple antibodies increases the chance of detecting autoimmune diabetes when it is present.
Do I need to fast for an IA-2 antibody blood test?
Fasting is usually not required for IA-2 antibody testing because it measures antibodies, not glucose. If you are also checking fasting glucose, insulin, or certain metabolic labs at the same visit, your clinician or the lab instructions may recommend fasting.
How is IA-2 antibody different from GAD65 antibody?
Both are islet autoantibodies used to evaluate autoimmune diabetes, but they target different proteins. GAD65 is commonly positive in adult-onset autoimmune diabetes, while IA-2 can add specificity and may be associated with a more classic type 1 pattern in some people. Many clinicians order both because either one can be positive while the other is negative.
If my IA-2 antibody is negative, can I still have type 1 diabetes or LADA?
Yes. A negative IA-2 antibody does not rule out autoimmune diabetes because other antibodies may be positive, and antibody levels can change over time. If suspicion remains, discuss broader antibody testing plus C-peptide and glucose/A1c.
When should IA-2 antibody testing be repeated?
Repeat testing is most often considered when the diagnosis is still uncertain, when your clinical course changes (for example, you need insulin sooner than expected), or when your clinician is building a more complete antibody profile. If you are trending, try to use the same lab method when possible so results are comparable.